Newborn blood spot screening: New opportunities, old problems

Journal of Inherited Metabolic Disease

Volumn 32, Issue 3, 2009, Pages 395-399

  Pollitt, Rodney J ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DEHYDROGENASE;

ACIDEMIA; BLOOD EXAMINATION; CLINICAL PRACTICE; CONFERENCE PAPER; CONGENITAL ADRENAL HYPERPLASIA; CONGENITAL HYPOTHYROIDISM; DIAGNOSTIC ACCURACY; GENE MUTATION; GENETIC DISORDER; GENOTYPE; HEALTH CARE POLICY; HUMAN; IMMUNOASSAY; MEDICAL TECHNOLOGY; METABOLIC DISORDER; MOLECULAR GENETICS; MULTIPLE ACYL COA DEHYDROGENASE DEFICIENCY; NEWBORN; NEWBORN SCREENING; PHENOTYPE; PHENYLKETONURIA; PREDICTION; TANDEM MASS SPECTROMETRY; WILSON DISEASE;

BLOOD SPECIMEN COLLECTION; HEMATOLOGIC TESTS; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING;

EID: 67349177124     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-9962-0     Document Type: Conference Paper

References (40)

1. American College of Medical Genetics. Newborn Screening Working Group (2006) Newborn screening: Towards a uniform screening panel and system. Genet Med 8 (Supplement): 1S-252S
2. Bodamer OA, Hoffmann GF, Lindner M (2007) Expanded newborn screening in Europe 2007. J Inherit Metab Dis 30: 439-444
3. Borrajo GJC (2007) Newborn screening in Latin America at the beginning of the 21st century. J Inherit Metab Dis 30: 466-481
4. Bowling FG, McGill JJ, Shepherd RW, Danks DM (1990) Screening for cystic fibrosis: Use of delta F508 mutation. Lancet 1: 925-926
5. Buist RM, Huntingdon K (2007) Scene from the USA: The illogic of mandating screening without also providing for treatment. J Inherit Metab Dis 30: 445-446
6. Chace DH, Millington DS, Terada N, Kahler SG, Roe CR, Hofman LF (1993) Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clin Chem 39: 66-71
7. 2 by tandem mass spectrometry. Clin Chem 53: 1448-1454
8. deWilde A, Sadilkova K, Sadilek M, Vasta V, Hahn SH (2008) Tryptic peptide analysis of ceruloplasmin in dried blood spots using liquid chromatography-tandem mass spectrometry: Application to newborn screening. Clin Chem 54: 1961-1968
9. Dhondt JL (2007) Neonatal screening: From the 'Guthrie age' to the 'genetic age. J Inherit Metab Dis 30: 418-422
10. Dobrowolski SF, Banas RA, Suzow JG, Berkley M, Naylor EW (2003) Analysis of common mutations in the galactose-1-phosphate uridyl transferase gene: New assays to increase the sensitivity and specificity of newborn screening for galactosemia. J Mol Diagn 5: 42-47
11. Dobrowolski SF, Ellingson CE, Caldovic L, Tuchman M (2007) Streamlined assessment of gene variants by high resolution melt profiling utilizing the ornithine transcarbamylase gene as a model system. Hum Mutat 28: 1133-1040
12. Downing M, Pollitt RJ (2008) Newborn screening in the UK - past, present and future. Ann Clin Biochem 45: 11-17
13. Frazier DM, Millington DS, McCandless SE, et al (2006) The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis 29: 76-85
14. Fukushi M (2007) An international training and support programme for the establishment of neonatal screening in developing countries. J Inherit Metab Dis 30: 593-595
15. Gelb MH, Turecek F, Scott CR, Chamoles NA (2006) Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders. J Inherit Metab Dis 29: 397-404
16. Gregersen N, Andresen BS, Pedersen CB, Olsen RKJ, Corydon TJ, Bross P (2008) Mitochondrial fatty acid oxidation defects - remaining challenges. J Inherit Metab Dis 31: 643-657
17. Guthrie R (1980) Organisation of a regional newborn screening laboratory. In: Bickel H, Guthrie R, Hammersen G, eds. Neonatal Screening for Inborn Errors of Metabolism. Berlin: Springer-Verlag, 259-270
18. Janzen N, Peter M, Sander S, et al (2007) Newborn screening for congenital adrenal hyperplasia: Additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 92: 479-485
19. Howell RR, Engelson G (2007) Structures for clinical follow-up: Newborn screening. J Inherit Metab Dis 30: 600-605
20. Khneisser I, Adib SM, Megarbane A, Lukacs Z (2009) International cooperation in the expansion of a newborn screening programme in Lebanon: A possible model for other programmes. J Inherit Metab Dis. doi: 10.1007/s10545-008-1008-5
21. Koch R (1980) Medical backup needed for newborn screening programmes. In: Bickel H, Guthrie R, Hammersen G, eds. Neonatal Screening for Inborn Errors of Metabolism. Berlin: Springer-Verlag, 271-273
22. Lindner M, Abdoh G, Fang-Hoffmann J, et al (2007) Implementation of extended neonatal screening and a metabolic unit in the state of Qatar: developing and optimising strategies in cooperation with the neonatal screening centre in Heidelberg. J Inherit Metab Dis 30: 522-529
23. Lindner M, Ho S, Kölker S, Abdoh G, Hoffmann GF, Burgard P (2008) Newborn screening for methylmalonic acidurias - optimization by statistical parameter combination. J Inherit Metab Dis 31: 379-385
24. Loeber JG (2007) Neonatal screening in Europe; the situation in 2004. J Inherit Metab Dis 30: 430-438
25. Matern D, Tortorelli S, Oglesbee D, Gavrilov D, Rinaldo P (2007) Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: The Mayo Clinic experience (2004-2007). J Inherit Metab Dis 30: 585-592
26. Millington DS, Kodo N, Norwood DL, Roe CR (1990) Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 13: 321-324
27. Padilla CD, Therrell BL (2007) Newborn screening in the Asia Pacific region. J Inherit Metab Dis 30: 490-506
28. Pollitt RJ (2006) International perspectives on newborn screening. J Inherit Metab Dis 29: 390-396
29. Pollitt RJ (2007) Introducing new screens: Why are we all doing different things? J Inherit Metab Dis 30: 423-429
30. President's Council on Bioethics (2008) The changing moral focus of newborn screening: An ethical inquiry by the President's Council of Bioethics. http://www.bioethics.gov/reports/newborn_screening/index.html (accessed 30/01/2009)
31. Saadallah AA, Rashed MS (2007) Newborn screening: Experiences in the Middle East and North Africa. J Inherit Metab Dis 30: 482-849
32. Solanki KK (2007) Training programmes for developing countries. J Inherit Metab Dis 30: 596-599
33. Therrell BL, Adams J (2007) Newborn screening in North America. J Inherit Metab Dis 30: 447-465
34. Torressani T, Biason-Lauber A (2007) Congenital adrenal hyperplasia: diagnostic advances. J Inherit Metab Dis 30: 563-575
35. Valle D, Manolio T (2008) Applying genomics to clinical problems - diagnostics, preventive medicine, pharmacogenetics. A white paper for the National Human Genome Research Institute. http://www.genome.gov/ About/Planning (accessed 30/01/2009)
36. van Spronsen FJ, Kiær Ahring K, Gizewska M (2009) PKU - What is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied Disorders. J Inherit Metab Dis 32: 58-64
37. Walter JH, Patterson A, Till J, et al (2009) Bloodspot acylcarnitine and amino acid analysis in cord blood samples; efficacy and reference data from a large cohort study. J Inherit Metab Dis 32: 95-101
38. Wilcken B (2007) Newborn screening for cystic fibrosis: Techniques and strategies. J Inherit Metab Dis 30: 537-543
39. Wilcken B (2008) The consequences of extended newborn screening programmes: Do we know who needs treatment? J Inherit Metab Dis 31: 173-177
40. Zhang XK, Elbin CS, Chuang WL, et al (2008) Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry. Clin Chem 54: 1725-1728